Mostrar el registro sencillo del ítem

dc.contributor.authorLuna-Sánchez, Marta
dc.contributor.authorHidalgo Gutiérrez, Agustín 
dc.contributor.authorChaves Serrano, Julio
dc.contributor.authorBarriocanal Casado, Eliana 
dc.contributor.authorSantos Fandila, Ángela
dc.contributor.authorRomero Pérez, Miguel 
dc.contributor.authorSayed, Ramy K. A.
dc.contributor.authorDuarte, Juan
dc.contributor.authorEscames Rosa, Germaine 
dc.contributor.authorAcuña Castroviejo, Darío 
dc.contributor.authorCuadros López, José Luis 
dc.date.accessioned2019-12-04T11:03:12Z
dc.date.available2019-12-04T11:03:12Z
dc.date.issued2017
dc.identifier.citationLuna‐Sánchez, M., Hidalgo‐Gutiérrez, A., Hildebrandt, T. M., Chaves‐Serrano, J., Barriocanal‐Casado, E., Santos‐Fandila, Á., ... & Schuelke, M. (2017). CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. EMBO molecular medicine, 9(1), 78-95.es_ES
dc.identifier.urihttp://hdl.handle.net/10481/58176
dc.description.abstractCoenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in the cellular metabolism. One of them is to function as an electron carrier in the reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes the first reaction in the hydrogen sulfide oxidation pathway. Therefore, SQR may be affected by CoQ deficiency. Using human skin fibroblasts and two mouse models with primary CoQ deficiency, we demonstrate that severe CoQ deficiency causes a reduction in SQR levels and activity, which leads to an alteration of mitochondrial sulfide metabolism. In cerebrum of Coq9R239X mice, the deficit in SQR induces an increase in thiosulfate sulfurtransferase and sulfite oxidase, as well as modifications in the levels of thiols. As a result, biosynthetic pathways of glutamate, serotonin, and catecholamines were altered in the cerebrum, and the blood pressure was reduced. Therefore, this study reveals the reduction in SQR activity as one of the pathomechanisms associated with CoQ deficiency syndrome.es_ES
dc.description.sponsorshipThis work was supported by grants from Ministerio de Economía y Competitividad, Spain, and the ERDF (SAF2013-47761-R, SAF2014-55523-R, RD12/0042/0011 and SAF201565786-R), from the Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (P10-CTS-6133), from the NIH (P01HD080642) and from the foundation “todos somos raros, todos somos únicos”. MLS is a predoctoral fellow from the Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía. LCL is supported by the “Ramón y Cajal” National Programme, Ministerio de Economía y Competitividad, Spain (RYC-2011-07643).es_ES
dc.language.isoenges_ES
dc.publisherEMBO Presses_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectBlood pressurees_ES
dc.subjectGlutathione es_ES
dc.subjectMitochondrial diseasees_ES
dc.subjectSQRes_ES
dc.titleCoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndromees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España